V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig). 1994

M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
INSERM U28, Hospital Broussais, Université Pierre et Marie Curie, Paris, France.

UI MeSH Term Description Entries
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I

Related Publications

M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
August 1990, Immunological reviews,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
January 1987, Immunogenetics,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
January 1989, Annual review of immunology,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
July 1998, Clinical and experimental immunology,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
January 2018, Frontiers in immunology,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
November 1990, Critical care medicine,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
December 1990, Behring Institute Mitteilungen,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
May 1992, International immunology,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
February 1999, Journal of Korean medical science,
M D Kazatchkine, and G Dietrich, and V Hurez, and N Ronda, and B Bellon, and F Rossi, and S V Kaveri
March 1990, Nucleic acids research,
Copied contents to your clipboard!